[Can a hydergine therapy lead to damage of the coronary vessels?].
Müller
Frank Ulrich
FU
Institut für Pharmakologie und Toxikologie, Westfälische Wilhelms Universität, Münster.
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D000544:Alzheimer Disease / Q000188:drug therapy; D000818:Animals; D003331:Coronary Vessels / Q000187:drug effects*; D004877:Ergoloid Mesylates / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D014665:Vasodilator Agents / Q000009:adverse effects* / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D014665:Vasodilator Agents; D004877:Ergoloid Mesylates